Viimased lisandused - Macular Degeneration - Age Related, Myopic, Choroidal Neovascular Membranes
|
Staphyloma and Atrophy with Vitreoretinal tractionvaatamisi: 106Only eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.apr 13, 2026
|
|
Staphyloma and Atrophy with Vitreoretinal tractionvaatamisi: 94Only eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.apr 13, 2026
|
|
Staphyloma and Atrophy with Vitreoretinal tractionvaatamisi: 80Only eye of patient with Albinism and decreasing vision now 5/200 in this 72 year old man. There is myopic tractional maculopathy. The patient also has albinism by history.apr 13, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 8683 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 7683 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 6883 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 10683 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 10183 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 7983 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 9183 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 8483 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 10983 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 7183 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 7283 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 6383 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 8383 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 8883 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 7483 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 8383 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Conversion to Wet AMD after Izervayvaatamisi: 7183 year old man whose left eye had minimal GA and converted from dry to wet AMD after a single Izervay treatmentmärts 15, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 17374 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 15374 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 19474 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 9374 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 10374 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 10474 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 8274 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 10274 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 8074 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 10174 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 10374 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 9474 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 11474 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 7974 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 9174 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 6874 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 9474 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 7774 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 10074 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 9174 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 8174 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 8474 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 7674 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 7674 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 6874 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Pattern Dystrophy with Collapsed Vitelliformvaatamisi: 8874 year old female with vision loss in eye with collapsed vitelliform lesion.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 10785 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 5885 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 6485 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 7285 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 6785 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 6185 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 6685 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 6785 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 8085 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 5885 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 6385 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 9485 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 6585 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 9285 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 9085 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 7385 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 10285 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 8085 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 8885 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 8585 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 8085 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 7685 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 7785 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 7985 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 9885 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 5885 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 8385 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 8185 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Peripapillary CNVM No Treatmentvaatamisi: 8485 year old with peripapillary CNVM watched for many years.veebr 18, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 8687 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 9287 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 10087 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 11087 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 11287 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 10787 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 11187 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 9387 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 9387 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 8887 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 11587 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 9687 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 10487 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 8387 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 11487 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 10987 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 8387 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Post Anti-VEGF RPE Tear (Vabysmo)vaatamisi: 10487 year old female with vision loss OS (20/125) given 1/4 dose vabysmo and developed RPE tear VA dropped to 20/400jaan 11, 2026
|
|
Stable Myopic Tractional Maculopathyvaatamisi: 12873 year old female with mild vision loss from table myopic tractional maculopathy in the left eyenov 23, 2025
|
|
Stable Myopic Tractional Maculopathyvaatamisi: 12273 year old female with mild vision loss from table myopic tractional maculopathy in the left eyenov 23, 2025
|
|
Stable Myopic Tractional Maculopathyvaatamisi: 11973 year old female with mild vision loss from table myopic tractional maculopathy in the left eyenov 23, 2025
|
|
Stable Myopic Tractional Maculopathyvaatamisi: 10773 year old female with mild vision loss from table myopic tractional maculopathy in the left eyenov 23, 2025
|
|
Stable Myopic Tractional Maculopathyvaatamisi: 12673 year old female with mild vision loss from table myopic tractional maculopathy in the left eyenov 23, 2025
|
|
Stable Myopic Tractional Maculopathyvaatamisi: 11173 year old female with mild vision loss from table myopic tractional maculopathy in the left eyenov 23, 2025
|
|
Stable Myopic Tractional Maculopathyvaatamisi: 10973 year old female with mild vision loss from table myopic tractional maculopathy in the left eyenov 23, 2025
|
|
|
|
